Bimodal high-affinity association of Brd4 with murine leukemia virus integrase and mononucleosomes

Nucleic Acids Research

Volumn 42, Issue 8, 2014, Pages 4861-4881

  Larue, Ross C ^a   Plumb, Matthew R ^a   Crowe, Brandon L ^a   Shkriabai, Nikoloz ^a   Sharma, Amit ^a   DiFiore, Julia ^a   Malani, Nirav ^b   Aiyer, Sriram S ^c   Roth, Monica J ^c   Bushman, Frederic D ^b   Foster, Mark P ^a   Kvaratskhelia, Mamuka ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; HISTONE H3; HISTONE H4; MURINE LEUKEMIA VIRUS INTEGRASE; PROTEIN BRD4; UNCLASSIFIED DRUG; VIRUS ENZYME; BRD4 PROTEIN, HUMAN; DNA; HISTONE; INTEGRASE; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HISTONE ACETYLATION; MASS SPECTROMETRY; MONONUCLEOSOME; NUCLEAR MAGNETIC RESONANCE; NUCLEOSOME; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION SITE; CHEMISTRY; ENZYMOLOGY; HEK293 CELL LINE; HUMAN; METABOLISM; MURINE LEUKEMIA VIRUS; PHYSIOLOGY; PROTEIN BINDING; VIRUS DNA CELL DNA INTERACTION;

DNA; HEK293 CELLS; HISTONES; HUMANS; INTEGRASES; LEUKEMIA VIRUS, MURINE; NUCLEAR PROTEINS; NUCLEOSOMES; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; TRANSCRIPTION FACTORS; VIRUS INTEGRATION;

EID: 84899793342     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku135     Document Type: Article

References (54)

1. Schroder, A.R., Shinn, P., Chen, H., Berry, C., Ecker, J.R. and Bushman, F. (2002) HIV-1 integration in the human genome favors active genes and local hotspots. Cell, 110, 521-529.
2. Wu, X., Li, Y., Crise, B. and Burgess, S.M. (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science, 300, 1749-1751.
3. Lewinski, M.K., Yamashita, M., Emerman, M., Ciuffi, A., Marshall, H., Crawford, G., Collins, F., Shinn, P., Leipzig, J., Hannenhalli, S. et al. (2006) Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog., 2, e60.
4. Cherepanov, P., Maertens, G., Proost, P., Devreese, B., Van Beeumen, J., Engelborghs, Y., De Clercq, E. and Debyser, Z. (2003) HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem., 278, 372-381.
5. Ciuffi, A., Llano, M., Poeschla, E., Hoffmann, C., Leipzig, J., Shinn, P., Ecker, J.R. and Bushman, F. (2005) A role for LEDGF/p75 in targeting HIV DNA integration. Nat. Med., 11, 1287-1289.
6. Llano, M., Saenz, D.T., Meehan, A., Wongthida, P., Peretz, M., Walker, W.H., Teo, W. and Poeschla, E.M. (2006) An essential role for LEDGF/p75 in HIV integration. Science, 314, 461-464.
7. Shun, M.C., Raghavendra, N.K., Vandegraaff, N., Daigle, J.E., Hughes, S., Kellam, P., Cherepanov, P. and Engelman, A. (2007) LEDGF/p75 functions downstream from preintegration complex formation to effect gene-specific HIV-1 integration. Genes Dev., 21, 1767-1778.
8. Ferris, A.L., Wu, X., Hughes, C.M., Stewart, C., Smith, S.J., Milne, T.A., Wang, G.G., Shun, M.C., Allis, C.D., Engelman, A. et al. (2010) Lens epithelium-derived growth factor fusion proteins redirect HIV-1 DNA integration. Proc. Natl Acad. Sci. USA, 107, 3135-3140.
9. Busschots, K., Vercammen, J., Emiliani, S., Benarous, R., Engelborghs, Y., Christ, F. and Debyser, Z. (2005) The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J. Biol. Chem., 280, 17841-17847.
10. Cherepanov, P., Ambrosio, A.L., Rahman, S., Ellenberger, T. and Engelman, A. (2005) Structural basis for the recognition between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl Acad. Sci. USA, 102, 17308-17313.
11. Hare, S., Di Nunzio, F., Labeja, A., Wang, J., Engelman, A. and Cherepanov, P. (2009) Structural basis for functional tetramerization of lentiviral integrase. PLoS Pathog., 5, e1000515.
12. Eidahl, J.O., Crowe, B.L., North, J.A., McKee, C.J., Shkriabai, N., Feng, L., Plumb, M., Graham, R.L., Gorelick, R.J., Hess, S. et al. (2013) Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes. Nucleic Acids Res., 41, 3924-3936.
13. Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.L. et al. (2000) Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science, 288, 669-672.
14. Wu, C. and Dunbar, C.E. (2011) Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity. Front Med., 5, 356-371.
15. Schmidt, M., Zickler, P., Hoffmann, G., Haas, S., Wissler, M., Muessig, A., Tisdale, J.F., Kuramoto, K., Andrews, R.G., Wu, T. et al. (2002) Polyclonal long-term repopulating stem cell clones in a primate model. Blood, 100, 2737-2743.
16. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E. et al. (2003) LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science, 302, 415-419.
17. Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K. et al. (2008) Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J. Clin. Invest., 118, 3132-3142.
18. Boztug, K., Schmidt, M., Schwarzer, A., Banerjee, P.P., Diez, I.A., Dewey, R.A., Bohm, M., Nowrouzi, A., Ball, C.R., Glimm, H. et al. (2010) Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N. Engl. J. Med., 363, 1918-1927.
19. Stein, S., Ott, M.G., Schultze-Strasser, S., Jauch, A., Burwinkel, B., Kinner, A., Schmidt, M., Kramer, A., Schwable, J., Glimm, H. et al. (2010) Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat. Med., 16, 198-204.
20. Ott, M.G., Schmidt, M., Schwarzwaelder, K., Stein, S., Siler, U., Koehl, U., Glimm, H., Kuhlcke, K., Schilz, A., Kunkel, H. et al. (2006) Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med., 12, 401-409.
21. Sharma, A., Larue, R.C., Plumb, M.R., Malani, N., Male, F., Slaughter, A., Kessl, J.J., Shkriabai, N., Coward, E., Aiyer, S.S. et al. (2013) BET proteins promote efficient murine leukemia virus integration at transcription start sites. Proc. Natl Acad. Sci. USA, 110, 12036-12041.
22. Gupta, S.S., Maetzig, T., Maertens, G.N., Sharif, A., Rothe, M., Weidner-Glunde, M., Galla, M., Schambach, A., Cherepanov, P. and Schulz, T.F. (2013) Bromo-and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration. J. Virol., 87, 12721-12736.
23. De Rijck, J., de Kogel, C., Demeulemeester, J., Vets, S., El Ashkar, S., Malani, N., Bushman, F.D., Landuyt, B., Husson, S.J., Busschots, K. et al. (2013) The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites. Cell Rep., 5, 886-894.
24. Studamire, B. and Goff, S.P. (2008) Host proteins interacting with the Moloney murine leukemia virus integrase: multiple transcriptional regulators and chromatin binding factors. Retrovirology, 5, 48.
25. Wu, S.Y. and Chiang, C.M. (2007) The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem., 282, 13141-13145.
26. Belkina, A.C. and Denis, G.V. (2012) BET domain co-regulators in obesity, inflammation and cancer. Nat. Rev. Cancer, 12, 465-477.
27. Moriniere, J., Rousseaux, S., Steuerwald, U., Soler-Lopez, M., Curtet, S., Vitte, A.L., Govin, J., Gaucher, J., Sadoul, K., Hart, D.J. et al. (2009) Cooperative binding of two acetylation marks on a histone tail by a single bromodomain. Nature, 461, 664-668.
28. Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W.B., Fedorov, O., Morse, E.M., Keates, T., Hickman, T.T., Felletar, I. et al. (2010) Selective inhibition of BET bromodomains. Nature, 468, 1067-1073.
29. Wu, S.Y., Lee, A.Y., Lai, H.T., Zhang, H. and Chiang, C.M. (2013) Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol. Cell, 49, 843-857.
30. Zhu, J., Gaiha, G.D., John, S.P., Pertel, T., Chin, C.R., Gao, G., Qu, H., Walker, B.D., Elledge, S.J. and Brass, A.L. (2012) Reactivation of latent HIV-1 by inhibition of BRD4. Cell Rep., 2, 807-816.
31. Boehm, D., Calvanese, V., Dar, R.D., Xing, S., Schroeder, S., Martins, L., Aull, K., Li, P.C., Planelles, V., Bradner, J.E. et al. (2012) BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle, 12, 452-462.
32. Hare, S., Gupta, S.S., Valkov, E., Engelman, A. and Cherepanov, P. (2010) Retroviral intasome assembly and inhibition of DNA strand transfer. Nature, 464, 232-236.
33. Jonsson, C.B., Donzella, G.A. and Roth, M.J. (1993) Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coli. J. Biol. Chem., 268, 1462-1469.
34. McKee, C.J., Kessl, J.J., Norris, J.O., Shkriabai, N. and Kvaratskhelia, M. (2009) Mass spectrometry-based footprinting of protein-protein interactions. Methods, 47, 304-307.
35. Larue, R., Gupta, K., Wuensch, C., Shkriabai, N., Kessl, J.J., Danhart, E., Feng, L., Taltynov, O., Christ, F., Van Duyne, G.D. et al. (2012) Interaction of the HIV-1 intasome with transportin 3 protein (TNPO3 or TRN-SR2). J. Biol. Chem., 287, 34044-34058.
36. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J. and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR, 6, 277-293.
37. Garrett, D.S., Seok, Y.J., Peterkofsky, A., Clore, G.M. and Gronenborn, A.M. (1997) Identification by NMR of the binding surface for the histidine-containing phosphocarrier protein HPr on the N-terminal domain of enzyme I of the Escherichia coli phosphotransferase system. Biochemistry, 36, 4393-4398.
38. Lin, Y.J., Umehara, T., Inoue, M., Saito, K., Kigawa, T., Jang, M.K., Ozato, K., Yokoyama, S., Padmanabhan, B. and Guntert, P. (2008) Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4. Protein Sci., 17, 2174-2179.
39. Barr, S.D., Leipzig, J., Shinn, P., Ecker, J.R. and Bushman, F.D. (2005) Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome. J. Virol., 79, 12035-12044.
40. Ocwieja, K.E., Brady, T.L., Ronen, K., Huegel, A., Roth, S.L., Schaller, T., James, L.C., Towers, G.J., Young, J.A., Chanda, S.K. et al. (2011) HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. PLoS Pathog., 7, e1001313.
41. Brady, T., Lee, Y.N., Ronen, K., Malani, N., Berry, C.C., Bieniasz, P.D. and Bushman, F.D. (2009) Integration target site selection by a resurrected human endogenous retrovirus. Genes Dev., 23, 633-642.
42. Roth, S.L., Malani, N. and Bushman, F.D. (2011) Gammaretroviral integration into nucleosomal target DNA in vivo. J. Virol., 85, 7393-7401.
43. Berry, C., Hannenhalli, S., Leipzig, J. and Bushman, F.D. (2006) Selection of target sites for mobile DNA integration in the human genome. PLoS Comput. Biol., 2, e157.
44. Vollmuth, F., Blankenfeldt, W. and Geyer, M. (2009) Structures of the dual bromodomains of the P-TEFb-activating protein Brd4 at atomic resolution. J. Biol. Chem., 284, 36547-36556.
45. Dey, A., Chitsaz, F., Abbasi, A., Misteli, T. and Ozato, K. (2003) The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl Acad. Sci. USA, 100, 8758-8763.
46. Umehara, T., Nakamura, Y., Jang, M.K., Nakano, K., Tanaka, A., Ozato, K., Padmanabhan, B. and Yokoyama, S. (2010) Structural basis for acetylated histone H4 recognition by the human BRD2 bromodomain. J. Biol. Chem., 285, 7610-7618.
47. Filippakopoulos, P., Picaud, S., Mangos, M., Keates, T., Lambert, J.P., Barsyte-Lovejoy, D., Felletar, I., Volkmer, R., Muller, S., Pawson, T. et al. (2012) Histone recognition and large-scale structural analysis of the human bromodomain family. Cell, 149, 214-231.
48. Leroy, G., Chepelev, I., Dimaggio, P.A., Blanco, M.A., Zee, B.M., Zhao, K. and Garcia, B.A. (2012) Proteogenomic characterization and mapping of nucleosomes decoded by Brd and HP1 proteins. Genome Biol., 13, R68.
49. Roth, M.J. (1991) Mutational analysis of the carboxyl terminus of the Moloney murine leukemia virus integration protein. J. Virol., 65, 2141-2145.
50. Turlure, F., Maertens, G., Rahman, S., Cherepanov, P. and Engelman, A. (2006) A tripartite DNA-binding element, comprised of the nuclear localization signal and two AT-hook motifs, mediates the association of LEDGF/p75 with chromatin in vivo. Nucleic Acids Res., 34, 1653-1675.
51. Rivat, C., Santilli, G., Gaspar, H.B. and Thrasher, A.J. (2012) Gene therapy for primary immunodeficiencies. Human Gene Ther., 23, 668-675.
52. Fischer, A., Hacein-Bey-Abina, S. and Cavazzana-Calvo, M. (2011) Gene therapy for primary adaptive immune deficiencies. J. Allergy Clin. Immunol., 127, 1356-1359.
53. Biasco, L., Baricordi, C. and Aiuti, A. (2012) Retroviral integrations in gene therapy trials. Mol. Ther. j. Am. Soc. Gene Ther., 20, 709-716.
54. Boztug, K., Dewey, R.A. and Klein, C. (2006) Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Curr. Opin. Mol. Ther., 8, 390-395.